Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Clinical trial NCT06182774 · RECRUITING
Trial details
- NCT number
- NCT06182774
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2032-01-31
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.